KRISHA MCHUGH: Open Payments
NPI 1629688718 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 9 payments from 7 companies in 2025. Trend: 2023 $40 · 2024 $99 · 2025 $262
Food & beverage: $227Education: $35
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Boston Scientific Corporation | 1 | $45 |
| Telix Pharmaceuticals | 1 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| 180 Medical, Inc. | 1 | $27 |
| Calyxo, Inc. | 1 | $22 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $21 |
Products named: GEMTESA, General - Kidney Stone Disease, ILLUCCIX, IMFINZI, CVAC ASPIRATION SYSTEM, PYLARIFY.
Industry payments across IN — which companies pay providers there.
